Zsuzsa Schaff

Summary

Affiliation: Semmelweis University
Country: Hungary

Publications

  1. pmc Enhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors
    Szofia Hajósi-Kalcakosz
    First Department of Pathology and Experimental Cancer Research, Semmelweis University, Ulloi ut 26, Budapest, H 1085, Hungary
    Diagn Pathol 7:86. 2012
  2. pmc Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study
    Anna Maria Tokes
    2nd Department of Pathology, Semmelweis University, Budapest, Hungary
    Breast Cancer Res 7:R296-305. 2005
  3. doi [Hepatocellular carcinoma--from macroscopy to molecular pathology]
    Zsuzsa Schaff
    Semmelweis Egyetem, Általános Orvostudományi Kar, II Patológiai Intézet, Budapest
    Orv Hetil 151:982-9. 2010
  4. doi [The value of liver biopsy in chronic hepatitis]
    Zsuzsa Schaff
    Semmelweis Egyetem, Általános Orvostudományi Kar II Patológiai Intézet Budapest Üllői út 93 1091
    Orv Hetil 152:856-8. 2011
  5. doi [MicroRNAs in hepatocarcinogenesis]
    Gabor Lendvai
    Semmelweis Egyetem, Általános Orvostudományi Kar II Patológiai Intézet Budapest Üllői út 93 1091
    Orv Hetil 153:978-89. 2012
  6. doi [Alterations in microRNA expression patterns in liver diseases]
    Gabor Lendvai
    Semmelweis Egyetem, Általános Orvostudományi Kar II Patológiai Intézet Budapest Üllői út 93 1091
    Orv Hetil 151:1843-53. 2010
  7. ncbi [Hepatocarcinogenesis in human liver]
    Peter Nagy
    I sz Patológiai és Kísérleti Rákkutató Intézet, Semmelweis Egyetem, Budapest, Hungary
    Magy Onkol 50:107-13. 2006
  8. ncbi [Pathology of liver tumors]
    Zsuzsa Schaff
    Semmelweis Egyetem, Általános Orvostudományi Kar, II Pathologiai Intézet, Budapest
    Orv Hetil 145:368-74. 2004
  9. ncbi [Hindgut cyst in the presacral region]
    Istvan Szabo
    Semmelweis Egyetem, Általános Orvostudományi Kar, II Szülészeti és Nogyógyászati Klinika, Budapest
    Orv Hetil 145:1141-3. 2004
  10. doi Agrin and CD34 immunohistochemistry for the discrimination of benign versus malignant hepatocellular lesions
    Péter Tátrai
    1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary
    Am J Surg Pathol 33:874-85. 2009

Collaborators

Detail Information

Publications20

  1. pmc Enhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors
    Szofia Hajósi-Kalcakosz
    First Department of Pathology and Experimental Cancer Research, Semmelweis University, Ulloi ut 26, Budapest, H 1085, Hungary
    Diagn Pathol 7:86. 2012
    ..It has been described to distinguish reliably hepatocellular carcinomas from liver adenomas and other benign hepatocellular lesions. However, no other types of malignant liver tumors were studied so far...
  2. pmc Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study
    Anna Maria Tokes
    2nd Department of Pathology, Semmelweis University, Budapest, Hungary
    Breast Cancer Res 7:R296-305. 2005
    ..We compared levels of protein and mRNA expression of three members of the claudin (CLDN) family in malignant breast tumours and benign lesions...
  3. doi [Hepatocellular carcinoma--from macroscopy to molecular pathology]
    Zsuzsa Schaff
    Semmelweis Egyetem, Általános Orvostudományi Kar, II Patológiai Intézet, Budapest
    Orv Hetil 151:982-9. 2010
    ....
  4. doi [The value of liver biopsy in chronic hepatitis]
    Zsuzsa Schaff
    Semmelweis Egyetem, Általános Orvostudományi Kar II Patológiai Intézet Budapest Üllői út 93 1091
    Orv Hetil 152:856-8. 2011
    ..It can be established however, that in recent years liver biopsies have become rather a selective than routine technique...
  5. doi [MicroRNAs in hepatocarcinogenesis]
    Gabor Lendvai
    Semmelweis Egyetem, Általános Orvostudományi Kar II Patológiai Intézet Budapest Üllői út 93 1091
    Orv Hetil 153:978-89. 2012
    ..In this article, the major and recent alterations of microRNA expression patterns in stages of hepatocarcinogenesis such as fibrosis, viral infections (hepatitis), cirrhosis and hepatocellular carcinoma are summarized...
  6. doi [Alterations in microRNA expression patterns in liver diseases]
    Gabor Lendvai
    Semmelweis Egyetem, Általános Orvostudományi Kar II Patológiai Intézet Budapest Üllői út 93 1091
    Orv Hetil 151:1843-53. 2010
    ....
  7. ncbi [Hepatocarcinogenesis in human liver]
    Peter Nagy
    I sz Patológiai és Kísérleti Rákkutató Intézet, Semmelweis Egyetem, Budapest, Hungary
    Magy Onkol 50:107-13. 2006
    ..Global gene expression profiling of hepatocellular carcinomas may result in a new classification of this tumor and can reveal new potential therapeutic targets...
  8. ncbi [Pathology of liver tumors]
    Zsuzsa Schaff
    Semmelweis Egyetem, Általános Orvostudományi Kar, II Pathologiai Intézet, Budapest
    Orv Hetil 145:368-74. 2004
    ..The cytological examination of samples taken by fine needle aspiration technique is becoming more and more significant in the differentiation of focal liver lesions...
  9. ncbi [Hindgut cyst in the presacral region]
    Istvan Szabo
    Semmelweis Egyetem, Általános Orvostudományi Kar, II Szülészeti és Nogyógyászati Klinika, Budapest
    Orv Hetil 145:1141-3. 2004
    ..The case is reported due to its relative rareness and the differential diagnostic questions emerging...
  10. doi Agrin and CD34 immunohistochemistry for the discrimination of benign versus malignant hepatocellular lesions
    Péter Tátrai
    1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary
    Am J Surg Pathol 33:874-85. 2009
    ..Moreover, whereas glypican-3 in some HCCs may appear in few scattered cells only, agrin is diffusely deposited in virtually all malignant lesions, which may prove advantageous in the evaluation of small specimens such as core biopsies...
  11. doi [New-onset diabetes mellitus and liver transplantation, with special consideration of recurrent hepatitis C]
    Balazs Nemes
    Semmelweis Egyetem, Általános Orvostudományi Kar Transzplantációs és Sebészeti Klinika Budapest Baross u 23 1082
    Orv Hetil 151:1062-71. 2010
    ..New-onset diabetes is a common complication after liver transplantation...
  12. doi Expression of tight junction protein claudin-4 in basal-like breast carcinomas
    Janina Kulka
    2nd Department of Pathology, Semmelweis University, 93 Ulloi ut, 1091, Budapest, Hungary
    Pathol Oncol Res 15:59-64. 2009
    ..This observation may be seen as a further proof that basal-like carcinomas represent a separable group amongst grade 3 breast carcinomas...
  13. ncbi [The recurrence of hepatitis C virus after liver transplantation]
    Balazs Nemes
    Semmelweis Egyetem, Általános Orvostudományi Kar, Transzplantációs és Sebészeti Klinika, Budapest, Baross u 23 25, 1082
    Orv Hetil 148:1971-9. 2007
    ..The main indication of the Hungarian Liver Transplant Program is liver cirrhosis caused by hepatitis C...
  14. ncbi Agrin, a novel basement membrane component in human and rat liver, accumulates in cirrhosis and hepatocellular carcinoma
    Péter Tátrai
    11st Institute of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary
    Lab Invest 86:1149-60. 2006
    ....
  15. ncbi [Clinical factors influencing the complications and survival of liver transplantation in Hungary]
    Balazs Nemes
    Semmelweis Egyetem, Általános Orvostudományi Kar, Transzplantációs és Sebészeti Klinika, Budapest
    Orv Hetil 146:1567-74. 2005
    ..Clinical factors in association with the complications and the outcome of liver transplantation. The Hungarian experience. Demography, morbidity, perioperative characteristics and mortality...
  16. ncbi [Proteoglycans in the liver]
    Ilona Kovalszky
    I sz Patológiai és Kísérleti Rákkutató Intézet, Semmelweis Egyetem, Budapest 1085, Hungary
    Magy Onkol 48:207-13. 2004
    ..This phenomenon calls attention to the importance of syndecan-1 shedding in the regulation of cell behavior...
  17. ncbi [Hepatitis viruses and hepatocarcinogenesis]
    Andras Kiss
    Általános Orvostudományi Kar, II Patológiai Intézet, Semmelweis Egyetem
    Orv Hetil 143:83-6. 2002
    ..Studies indicate that in the near future viral hepatitis will be of increasing importance in the etiology of HCC...
  18. ncbi [Novel factors playing a role in the pathomechanism of diffuse liver diseases: apoptosis and hepatic stem cells]
    Zsuzsa Schaff
    Semmelweis Egyetem, Általános Orvostudományi Kar, II sz Pathologiai Intézet, Budapest
    Orv Hetil 145:1787-93. 2004
    ..If the latter is true, this can fundamentally change our view on the pathomechanism of liver diseases, making possible numerous novel therapeutic treatments...
  19. ncbi [Unilateral Sertoli-cell androblastoma in the ovary of a young woman]
    Roland Istók
    Semmelweis Egyetem, Általános Orvostudományi Kar, II Pathologiai Intézet
    Orv Hetil 145:693-6. 2004
    ..Biologically it follows a low-malignant course with a fair prognosis, long-term complex patient follow up is necessary after unilateral oophorectomy of the diseased organ...
  20. ncbi [Malignant rhabdoid tumour in the liver]
    Judit Halasz
    Semmelweis Egyetem, Általános Orvostudományi Kar, II sz Pathologiai Intézet, Budapest
    Orv Hetil 145:1439-43. 2004
    ..Intraoperative liver biopsy and few days later the autopsy histology showed a malignant rhabdoid tumour. Authors describe the clinical and morphological features of a rare case of primary hepatic rhabdoid tumour...